Sestrin2 Regulates Endoplasmic Reticulum Stress-Dependent Ferroptosis to Engage Pulmonary Fibrosis by Nuclear Factor Erythroid 2-Related Factor 2/Activating Transcription Factor 4 (NRF2/ATF4)
Journal of Immunology Research · 07.11.2023 · 2023 · 1-19
DOI: 10.1155/2023/9439536 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Immunology Research, erschienen am 07.11.2023. Verfasst von Zhaoxing Dong und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Respiratory and Critical Care Medicine, Ningbo No. 2 Hospital, Ningbo 315000, Zhejiang Province, China. Hauptthemen laut MEDLINE: Pulmonary Fibrosis, Ferroptosis. Die Arbeit wurde bisher 13-mal zitiert (Crossref) und nennt 47 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China, Yongjiang Talent Attraction Project, Kunming Medical University.
Abstract (Originalsprache)
Pulmonary fibrosis (PF) can lead to chronic inflammation, the destruction of alveoli and irreversible lung damage. Sestrin2 is a highly protective stress-inducible protein that is involved in the cell response to various stress factors and the regulation of homeostasis and has a certain protective effect against PF. In this study, TGF-β1 was used to establish a PF cell model. Bleomycin was used to induce PF in mice, and the expression levels of related proteins were detected by western blotting. The levels of the inflammatory cytokine, TNF-α, IL-6, and IL-1β were detected by enzyme-linked immunosorbent assays. Immunoprecipitation was used to verify the interaction between ATF4 and NRF2 and between Sestrin2 and NRF2 to explore the specific mechanism by which Sestrin2 affects PF. The results showed that Sestrin2 inhibited fibroblast-to-myofibroblast transition (FMT), improved inflammation, promoted cell proliferation, and alleviated PF. Activating transcription factor 4/nuclear factor erythroid 2-related factor 2 (NRF2/ATF4) signaling pathway activation could alleviate endoplasmic reticulum stress, inhibit ferroptosis and FMT, and reduce reactive oxygen species levels, thereby alleviating PF. Overexpression of ATF4 and the addition of a ferroptosis inducer reversed Sestrin2-mediated alleviation of PF. In conclusion, Sestrin2 alleviates PF and endoplasmic reticulum stress-dependent ferroptosis through the NRF2/ATF4 pathway.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Respiratory and Critical Care Medicine, Ningbo No. 2 Hospital, Ningbo 315000, Zhejiang Province, China.
- Department of Respiratory and Critical Care Medicine, Xiangshan Red Cross Taiwan Compatriot Hospital Medical and Health Group, Ningbo 315000, Zhejiang, China.
ORCID-Profile: Zhaoxing Dong, Xuekui Du
Förderung
- National Natural Science Foundation of China
- Yongjiang Talent Attraction Project
- Kunming Medical University
- Ningbo Clinical Research Center for Respiratory System Disease
- Ningbo Health Branding Subject Fund
Zitieren
APA
Dong, Z., Li, T., Wang, C., Zhou, Y., Tong, Z., & Du, X. (2023). Sestrin2 Regulates Endoplasmic Reticulum Stress-Dependent Ferroptosis to Engage Pulmonary Fibrosis by Nuclear Factor Erythroid 2-Related Factor 2/Activating Transcription Factor 4 (NRF2/ATF4). Journal of Immunology Research, 2023, 1-19. https://doi.org/10.1155/2023/9439536
Vancouver
Dong Z, Li T, Wang C, Zhou Y, Tong Z, Du X. Sestrin2 Regulates Endoplasmic Reticulum Stress-Dependent Ferroptosis to Engage Pulmonary Fibrosis by Nuclear Factor Erythroid 2-Related Factor 2/Activating Transcription Factor 4 (NRF2/ATF4). Journal of Immunology Research. 2023;2023:1-19. doi:10.1155/2023/9439536
BibTeX
@article{Dong2023,
author = {Dong, Zhaoxing and Li, Ting and Wang, Cenli and Zhou, Yong and Tong, Zhongkai and Du, Xuekui},
title = {Sestrin2 Regulates Endoplasmic Reticulum Stress-Dependent Ferroptosis to Engage Pulmonary Fibrosis by Nuclear Factor Erythroid 2-Related Factor 2/Activating Transcription Factor 4 (NRF2/ATF4)},
journal = {Journal of Immunology Research},
year = {2023},
volume = {2023},
pages = {1--19},
doi = {10.1155/2023/9439536}
}
EUVIMED